comparemela.com

Latest Breaking News On - Director randal - Page 8 : comparemela.com

Magnolia Capital Advisors LLC Buys New Shares in Precigen, Inc. (NASDAQ:PGEN)

Magnolia Capital Advisors LLC purchased a new stake in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 39,997 shares of the biotechnology company’s stock, valued at approximately $57,000. Other large investors have also recently bought and […]

Magnolia Capital Advisors LLC Makes New Investment in Precigen, Inc. (NASDAQ:PGEN)

Magnolia Capital Advisors LLC purchased a new position in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 39,997 shares of the biotechnology company’s stock, valued at approximately $57,000. Other hedge funds also recently added to or reduced their stakes in the company. Emfo LLC […]

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating on the company. The average 1 […]

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $40.23 Consensus Target Price from Analysts

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) has received an average rating of “Moderate Buy” from the thirteen analysts that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12 month price objective among […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.